［1］ Capello D, Rasi S, Oreste P, et al. Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients［J］. J Pathol，2009，218(4):478-486.

［2］ Jiang Y, Villeneuve P J, Fenton S S, et al. Liver transplantation and subsequent risk of cancer: findings from a Canadian cohort study［J］. Liver Transpl， 2008，14(11): 1588-1597.

［3］ Costes-Martineau V, Delfour C, Obled S, et al. Anaplastic lymphoma kinase (ALK) protein expressing lymphoma after liver transplantation: case report and literature review［J］. J Clin Pathol，2002，55(11):868-871

［4］ Aberg F, Pukkala E, Hckerstedt K, et al. Risk of malignant neoplasms after liver transplantation: a population-based study［J］.Liver Transpl， 2008，14(10): 1428 -1436.

［5］ Tsai D E,Hardy C L,Tomaszewski J E,et al.Reductionin immunosuppressionas initial therapy for posttransplant lympophproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients［J］. Transplantation, 2001，71(8):1076-1088.